(Date:11/25/2009)..., Nov. 25 Biotech firm Replikins L...ta from the 1918 pandemic through the prediction, ...c, today issued its latest biochemical analysis of...of the H1N1 ("Swine Flu") virus has dropped from i...nt outbreak in the spring of 2009 to resting non-e...
(Date:11/25/2009)..., ,, BOCA RATON, Fla., Nov. 25 /PRNewswir... year. Not so for BodyLogicMD. The nation,s large...s specializing exclusively in medically supervised... physicians in its network since November 200... to add more physician-owned centers, including on...
(Date:11/25/2009)...EIJING, Nov. 25 /PRNewswire-Asia/ -- Sinovac Biote...f vaccines, announced today that it executed,a joi...lian) Vaccine,Technology Co., Ltd. (Sinovac Dalian...ercialize human-use vaccines. Sinovac will contrib... commercializing world-class vaccines; the,other p...
(Date:11/25/2009)...Nov. 25 Ardea Bioscience...y D. Quart, Pharm.D., president and chief executiv...Annual Health Care Conference. , ,Presentation de...ealth Care Conference,Date: Tuesday, December...n: The New York Palace Hotel, New York, NY,Webcas...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2...nc.,(Nasdaq: RDYN ) today announced its financial...d December 31, 2007., Replidyne reported a net lo...ecember 31, 2007, or a net loss per basic and dilu... net loss of $9.6 million, or $0.36 per,basic and ...er 31, 2006.,For the year ended December 31, 2007,...
...ical and Vaccine Immunology, ANN ARBOR, Mich., Fe...niversity of Michigan have demonstrated their nasa... against 77 times the,potentially lethal dose of s...accines for smallpox. Vaccinia virus is related to...The new vaccine confers a high level of safety bec...
...ertified Partner Provides Framework, for Next Gene... Solutions, ORLANDO, Fla., Feb. 26 Netsmart Tech...ide software and services for health and,human ser...ed Microsoft,Gold Certified Partner status in the ...de at the 2008 Annual Healthcare Information and,M...
Other Biology Technology:Replidyne Announces 2007 Fourth Quarter and Full Year Results 2Replidyne Announces 2007 Fourth Quarter and Full Year Results 3Replidyne Announces 2007 Fourth Quarter and Full Year Results 4Replidyne Announces 2007 Fourth Quarter and Full Year Results 5Replidyne Announces 2007 Fourth Quarter and Full Year Results 6Replidyne Announces 2007 Fourth Quarter and Full Year Results 7Nasal Vaccine for Smallpox Confers High Levels of Immunity Without Safety Risks 2Nasal Vaccine for Smallpox Confers High Levels of Immunity Without Safety Risks 3Netsmart Technologies Announces Development Program on Microsoft for Local Public Health Clinic Management and Vital Records Software 2Netsmart Technologies Announces Development Program on Microsoft for Local Public Health Clinic Management and Vital Records Software 3Rabbit Anti-CSNK2A1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
UV LAMP 254 NM 8 WATT from GE Healthcare, formerly Amersham Biosciences
... SelectFX Alexa Fluor 488 Cytochrome c Apoptosis D... detect cytochrome c in fixed cells. The kit emplo...lexa Fluor 488 dye-labeled secondary antibody. Ale...e that is compatible with filters and instrument s...
Mouse Anti-NEUROFILAMENTS 140+160 KD Monoclonal Antibody, Unconjugated, Clone BIO-46H from AbD Serotec
Biology Products: